Results for tag: "Oropharyngeal Cancer Drug"

The Oropharyngeal Cancer Drug market is a subset of the Oncology Drugs market, which focuses on the treatment of cancer. Oropharyngeal cancer drugs are used to treat cancers of the oropharynx, which is the area of the throat behind the mouth. These drugs are typically used in combination with other treatments such as radiation and surgery. Commonly used oropharyngeal cancer drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. These drugs are designed to target the cancer cells while minimizing the damage to healthy cells. The Oropharyngeal Cancer Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Novartis. Other companies such as Eli Lilly, Amgen, and Roche also offer treatments for oropharyngeal cancer. Show Less Read more